한글목차

의료용 동위원소 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 72억 6,000만 달러에서 2026년에는 77억 9,000만 달러에 이르고, CAGR 7.4%로 성장할 전망입니다. 지난 몇 년간의 성장은 진단 부문에서 테크네튬 99m이 잘 활용되고, 병원 핵의학 부문의 확대, 암 진단율 증가, 동위원소 공급의 원자로 의존도 증가, 의료용 이미징 장비의 발전 등에 기인합니다.

의료용 동위원소 시장 규모는 향후 몇 년간에 견고성장이 전망됩니다. 2030년에는 100억 5,000만 달러에 이르고, CAGR은 6.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 만성질환 유병률 증가, 표적 방사선 치료 수요 증가, 사이클로트론 시설 투자, 맞춤형 의료의 발전, 동위원소 제조 기술의 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 진단 영상에서의 방사성 동위원소 사용 증가, 핵의학 치료의 도입 확대, 정밀 종양 치료에 대한 수요 증가, 사이클로트론 기반 동위원소 생산 확대, 단수명 동위원소 공급망에 대한 관심 증가 등을 들 수 있습니다.

암과 심장질환의 발생률 증가는 향후 의료용 동위원소 시장의 성장을 가속할 것으로 예측됩니다. 암과 심장 질환의 발생률은 특정 기간 동안 인구 내에서 이러한 질환이 얼마나 자주 발생하고 지속되는지를 나타내는 지표로, 광범위한 공중 보건 추세와 예방 전략의 효과를 반영합니다. 이러한 질환 증가 추세는 기술 사용과 사무직 중심의 직업으로 인한 현대인의 좌식 생활과 관련이 있으며, 이는 신체 활동량 감소를 초래하고 있습니다. 의료용 동위원소는 양전자방출단층촬영(PET), 단일광자방출단층촬영(SPECT)과 같은 영상진단법으로 암, 심장질환의 진단 및 치료, 방사선 치료, 방사성 스텐트 등의 치료 응용에 중요한 역할을 하고 있습니다. 예를 들어, 맥밀런 암 지원 단체에 따르면 2024년 8월 현재 영국에서 300만 명 이상이 암을 앓고 있으며, 이 숫자는 2025년까지 350만 명, 2030년까지 400만 명, 2040년까지 530만 명에 달할 것으로 예측했습니다. 따라서 암과 심장병의 발병률 증가가 의료용 동위원소 시장의 성장을 주도하고 있습니다.

의료용 동위원소 시장의 주요 기업들은 경쟁 우위를 강화하기 위해 전략적 제휴에 집중하고 있습니다. 전략적 제휴는 조직 간 공식적인 파트너십을 맺고 공동의 목표를 추구하며 상호 이익이 되는 결과를 도출하기 위해 노력하는 것을 말합니다. 예를 들어, 2023년 9월, 미국에 본사를 둔 의료 기술 기업 International Isotopes Inc.는 미국에 본사를 둔 생체 의료기기 제조업체인 Phantech Medical과 제휴하여 고객용 솔루션 통합을 위해 협력했습니다. 양사는 이번 협력을 통해 의료 영상 및 치료 진단(ceranostics) 용도를 지원하는 혁신적인 밀폐형 선원을 설계, 제조, 판매함으로써 전임상 이미징 부문에서 교정 및 기준선원 시장을 혁신적으로 변화시키는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교와 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 전략

제41장 부록

영문목차

Medical isotopes are radioisotopes utilized in medicine, emitting positrons or gamma rays for diagnostic purposes. These isotopes aid in visualizing and targeting specific tissues or abnormalities within the body, facilitating tasks such as evaluating heart function, assessing blood flow to the heart muscle, and diagnosing coronary artery disease.

The main product types of medical isotopes comprise stable isotopes and radioisotopes. Stable isotopes are versions of chemical elements that do not decay over time, retaining their atomic structure indefinitely. Production methods for medical isotopes include neutron activation, cyclotrons, nuclear reactors, and others. These isotopes find applications in nuclear therapy, equipment radioactive sources, and diagnostic procedures. End users of medical isotopes include hospitals, diagnostic centers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the medical isotopes market by increasing costs related to imported nuclear materials, specialized equipment, and isotope processing components essential for medical applications. These impacts are most evident in diagnostic and therapeutic isotope supply chains across north america, europe, and asia pacific, where cross border movement of radioactive materials is tightly regulated. Higher costs and logistical delays have challenged timely isotope availability for hospitals and diagnostic centers. Conversely, tariffs have driven investments in domestic production facilities, cyclotron installations, and localized supply networks, improving long term supply security and healthcare resilience.

The medical isotopes market research report is one of a series of new reports from The Business Research Company that provides medical isotopes market statistics, including medical isotopes industry global market size, regional shares, competitors with a medical isotopes market share, detailed medical isotopes market segments, market trends and opportunities, and any further data you may need to thrive in the medical isotopes industry. This medical isotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical isotopes market size has grown strongly in recent years. It will grow from $7.26 billion in 2025 to $7.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to established use of technetium 99m in diagnostics, expansion of hospital nuclear medicine departments, growth in cancer diagnosis rates, reliance on nuclear reactors for isotope supply, advances in medical imaging equipment.

The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $10.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising demand for targeted radiotherapy, investment in cyclotron infrastructure, growth of personalized medicine, technological advancements in isotope production methods. Major trends in the forecast period include rising use of radioisotopes in diagnostic imaging, growing adoption of nuclear medicine therapies, increasing demand for precision oncology treatments, expansion of cyclotron based isotope production, higher focus on short lived isotope supply chains.

The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to how frequently these conditions occur and persist within a population over a given period, reflecting broader public health patterns and the effectiveness of prevention strategies. The increasing prevalence of these diseases is linked to modern sedentary lifestyles driven by technology use and desk-based occupations, which reduce physical activity levels. Medical isotopes play a critical role in diagnosing and treating cancer and heart disease through imaging modalities such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as in therapeutic applications including radiation therapy and radioactive stents. For instance, in August 2024, according to Macmillan Cancer Support, more than 3 million people in the UK were living with cancer, a number projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, rising cancer and heart disease rates are driving the growth of the medical isotope market.

Major companies in the medical isotope market are focusing on strategic collaborations to strengthen their competitive position. Strategic collaborations involve formal partnerships between organizations to pursue shared goals and deliver mutually beneficial outcomes. For example, in September 2023, International Isotopes Inc., a US-based medical technology company, partnered with Phantech Medical, a US-based biomedical hardware manufacturer, to integrate solutions for their customers. Through this collaboration, the companies aim to transform the calibration and reference sources market for pre-clinical imaging by designing, manufacturing, and distributing innovative sealed sources that support medical imaging and theranostics applications.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed amount. This acquisition provides Telix with enhanced access to ARTMS' cutting-edge radiopharmaceutical production technologies, strengthening its capabilities in developing and commercializing targeted radiopharmaceuticals for cancer imaging and therapy. ARTMS Inc. is a Canada-based medical equipment manufacturer specializing in technologies that improve the production of diagnostic imaging isotopes.

Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotop, Coqui RadioPharmaceuticals Corp., Jubilant DraxImage Inc.

North America was the largest region in the medical isotopes market in 2025. The regions covered in the medical isotopes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical isotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The medical isotopes market consists of sales of technetium-99m, carbon-11, and gallium-68 which serve specific purposes in medical diagnosis and therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Isotopes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical isotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical isotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical isotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Diagnostic Radioisotopes; Therapeutic Radioisotopes; Theranostic Radioisotopes
• 2) By Production Method: Neutron Activation; Cyclotron; Nuclear Reactor; Other Production Method
• 3) By Application: Diagnostic Imaging; Targeted Radionuclide Therapy; Brachytherapy; Radiopharmaceutical Research & Development
• 4) By End Use: Hospitals; Diagnostic Imaging Centers; Research Institutes
• Subsegments:
• 1) By Diagnostic Radioisotopes: Technetium-99m; Fluorine-18; Gallium-68; Iodine-123; Carbon-11; Other Diagnostic Radioisotopes
• 2) By Therapeutic Radioisotopes: Iodine-131; Lutetium-177; Yttrium-90; Strontium-89; Samarium-153; Actinium-225; Other Therapeutic Radioisotopes
• 3) By Theranostic Radioisotopes: Gallium-68 / Lutetium-177 Pairs; Copper-64 / Copper-67 Pairs; Iodine-123 / Iodine-131 Pairs; Scandium-44 / Scandium-47 Pairs; Terbium Isotope Pairs; Other Theranostic Radioisotopes
• Companies Mentioned: Rosatom State Atomic Energy Corporation; Bayer AG; Siemens Healthineers AG; GE HealthCare; Urenco Ltd.; Lantheus Holdings Inc.; Curium Pharma; Canadian Nuclear Laboratories; Eckert & Ziegler Strahlen- und Medizintechnik AG.; Advanced Accelerator Applications a Novartis company; Nordion Inc.; NTP Radioisotopes SOC Ltd.; The Institute for Radioelements (IRE); NorthStar Medical Radioisotopes LLC; Isotopen Technologien Munchen AG (ITM); EczacIbasI-Monrol Nuclear Products Co.; SHINE Medical Technologies LLC; Blue Earth Diagnostics Limited; Isologic Innovative Radiopharmaceuticals; IBA Radiopharma Solutions; Izotop; Coqui RadioPharmaceuticals Corp.; Jubilant DraxImage Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Medical Isotopes Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Medical Isotopes Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Medical Isotopes Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Medical Isotopes Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Use Of Radioisotopes In Diagnostic Imaging
  • 4.2.2 Growing Adoption Of Nuclear Medicine Therapies
  • 4.2.3 Increasing Demand For Precision Oncology Treatments
  • 4.2.4 Expansion Of Cyclotron Based Isotope Production
  • 4.2.5 Higher Focus On Short Lived Isotope Supply Chains

5. Medical Isotopes Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Imaging Centers
• 5.3 Nuclear Medicine Clinics
• 5.4 Research Institutes
• 5.5 Cancer Treatment Centers

6. Medical Isotopes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Isotopes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Medical Isotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Medical Isotopes Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Medical Isotopes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Medical Isotopes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Isotopes Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Isotopes Market Segmentation

• 9.1. Global Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Radioisotopes, Therapeutic Radioisotopes, Theranostic Radioisotopes
• 9.2. Global Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
• 9.3. Global Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Imaging, Targeted Radionuclide Therapy, Brachytherapy, Radiopharmaceutical Research & Development
• 9.4. Global Medical Isotopes Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Imaging Centers, Research Institutes
• 9.5. Global Medical Isotopes Market, Sub-Segmentation Of Diagnostic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Carbon-11, Other Diagnostic Radioisotopes
• 9.6. Global Medical Isotopes Market, Sub-Segmentation Of Therapeutic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Iodine-131, Lutetium-177, Yttrium-90, Strontium-89, Samarium-153, Actinium-225, Other Therapeutic Radioisotopes
• 9.7. Global Medical Isotopes Market, Sub-Segmentation Of Theranostic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gallium-68 / Lutetium-177 Pairs, Copper-64 / Copper-67 Pairs, Iodine-123 / Iodine-131 Pairs, Scandium-44 / Scandium-47 Pairs, Terbium Isotope Pairs, Other Theranostic Radioisotopes

10. Medical Isotopes Market Regional And Country Analysis

• 10.1. Global Medical Isotopes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Medical Isotopes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Isotopes Market

• 11.1. Asia-Pacific Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Isotopes Market

• 12.1. China Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Isotopes Market

• 13.1. India Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Isotopes Market

• 14.1. Japan Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Isotopes Market

• 15.1. Australia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Isotopes Market

• 16.1. Indonesia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Isotopes Market

• 17.1. South Korea Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Isotopes Market

• 18.1. Taiwan Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Isotopes Market

• 19.1. South East Asia Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Isotopes Market

• 20.1. Western Europe Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Isotopes Market

• 21.1. UK Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Isotopes Market

• 22.1. Germany Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Isotopes Market

• 23.1. France Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Isotopes Market

• 24.1. Italy Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Isotopes Market

• 25.1. Spain Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Isotopes Market

• 26.1. Eastern Europe Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Isotopes Market

• 27.1. Russia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Isotopes Market

• 28.1. North America Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Isotopes Market

• 29.1. USA Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Isotopes Market

• 30.1. Canada Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Isotopes Market

• 31.1. South America Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Isotopes Market

• 32.1. Brazil Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Isotopes Market

• 33.1. Middle East Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Isotopes Market

• 34.1. Africa Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Isotopes Market Regulatory and Investment Landscape

36. Medical Isotopes Market Competitive Landscape And Company Profiles

• 36.1. Medical Isotopes Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Medical Isotopes Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Medical Isotopes Market Company Profiles
  • 36.3.1. Rosatom State Atomic Energy Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Urenco Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Medical Isotopes Market Other Major And Innovative Companies

• Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions

38. Global Medical Isotopes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Isotopes Market

40. Medical Isotopes Market High Potential Countries, Segments and Strategies

• 40.1 Medical Isotopes Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Medical Isotopes Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Medical Isotopes Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer